Tazidime and Swelling face - a phase IV clinical study of FDA data

Summary:

Swelling face is reported as a side effect among people who take Tazidime (ceftazidime), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Acyclovir, and have Fever.

The phase IV clinical study analyzes which people have Swelling face when taking Tazidime. It is created by eHealthMe based on reports of 10,389 people who have side effects when taking Tazidime from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Swelling face?

Swelling face is found to be associated with 1,901 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Swelling face.

On Jul, 07, 2026

10,389 people reported to have side effects when taking Tazidime.
Among them, 46 people (0.44%) have Swelling face.

Among these 46 people:

How long have people been on Tazidime when they have Swelling face? *

What is the gender of people who have Swelling face when taking Tazidime? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Swelling face when taking Tazidime? *

What are other drugs people take besides Tazidime? *

What are other side effects people have besides Swelling face? *

Fever: 23 people, 50.00%
Diarrhea: 17 people, 36.96%
Nausea (feeling of having an urge to vomit): 15 people, 32.61%
Thrombocytopenia (decrease of platelets in blood): 15 people, 32.61%
Hypotension (abnormally low blood pressure): 15 people, 32.61%
Acute Myocardial Infarction (acute heart attack): 15 people, 32.61%
Hyperbilirubinaemia (excess of bilirubin in the blood): 15 people, 32.61%
Septic Shock (shock due to blood infection): 14 people, 30.43%
Renal Impairment (severely reduced kidney function): 14 people, 30.43%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 14 people, 30.43%

What are the existing conditions these people have? *

Fever: 16 people, 34.78%
High Blood Pressure: 14 people, 30.43%
Tumor Lysis Syndrome: 13 people, 28.26%
Hyperlipidaemia (presence of excess lipids in the blood): 13 people, 28.26%
Hairy Cell Leukaemia (a type of blood cancer): 13 people, 28.26%
Pneumonia: 5 people, 10.87%
Diffuse Large B-Cell Lymphoma Refractory (cancer of b cells, a type of white blood cell-relapsed): 4 people, 8.70%
Cardiomyopathy (weakening of the heart muscle): 3 people, 6.52%
Infection: 3 people, 6.52%
Hiv Infection: 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and have Swelling face?

- Check whether Swelling face is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazidime:

Tazidime (10,409 reports)

Swelling face treatments and more:

Swelling face (70,017 reports)

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling face:

Swelling face (1,901 drugs)

Browse all the conditions that are associated with Swelling face:

Swelling face (2,206 conditions)

Related publications that referenced our studies

Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Tazidime) and Tazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.